NumerixS Investment Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-189
| Closed | -$19K | – | 1181 |
|
2020
Q1 | $19K | Sell |
189
-1,211
| -87% | -$122K | 0.01% | 805 |
|
2019
Q4 | $209K | Sell |
1,400
-2,600
| -65% | -$388K | 0.04% | 479 |
|
2019
Q3 | $513K | Buy |
+4,000
| New | +$513K | 0.13% | 160 |
|
2019
Q2 | – | Sell |
-9,200
| Closed | -$1.29M | – | 1210 |
|
2019
Q1 | $1.29M | Buy |
9,200
+7,600
| +475% | +$1.07M | 0.17% | 139 |
|
2018
Q4 | $195K | Buy |
1,600
+300
| +23% | +$36.6K | 0.06% | 352 |
|
2018
Q3 | $216K | Sell |
1,300
-3,100
| -70% | -$515K | 0.04% | 558 |
|
2018
Q2 | $765K | Sell |
4,400
-1,100
| -20% | -$191K | 0.17% | 160 |
|
2018
Q1 | $812K | Buy |
5,500
+3,299
| +150% | +$487K | 0.2% | 111 |
|
2017
Q4 | $296K | Buy |
+2,201
| New | +$296K | 0.07% | 342 |
|
2017
Q1 | – | Sell |
-700
| Closed | -$76K | – | 1260 |
|
2016
Q4 | $76K | Sell |
700
-1,700
| -71% | -$185K | 0.01% | 906 |
|
2016
Q3 | $292K | Sell |
2,400
-17,399
| -88% | -$2.12M | 0.04% | 561 |
|
2016
Q2 | $2.8M | Buy |
19,799
+2,440
| +14% | +$345K | 0.39% | 35 |
|
2016
Q1 | $2.27M | Buy |
17,359
+3,600
| +26% | +$470K | 0.26% | 81 |
|
2015
Q4 | $1.93M | Sell |
13,759
-31,525
| -70% | -$4.43M | 0.24% | 85 |
|
2015
Q3 | $6.01M | Buy |
45,284
+40,284
| +806% | +$5.35M | 0.69% | 27 |
|
2015
Q2 | $880K | Buy |
+5,000
| New | +$880K | 0.12% | 224 |
|
2015
Q1 | – | Sell |
-2,302
| Closed | -$377K | – | 631 |
|
2014
Q4 | $377K | Buy |
+2,302
| New | +$377K | 0.13% | 240 |
|